NASDAQ:CORT
$23.98
(
-2.20%
)
Friday, 26th May 2023
Corcept Therapeutics Incorporated Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $21.84 | $25.67 | Friday, 26th May 2023 CORT stock ended at $23.98. This is 2.2% less than the trading day before Thursday, 25th May 2023. During the day the stock fluctuated 2.48% from a day low at $23.95 to a day high of $24.55. |
| 90 days | $17.86 | $25.67 | |
| 52 weeks | $17.86 | $30.14 |
Historical Corcept Therapeutics Incorporated prices
| Date | Open | High | Low | Close | Volume |
| 2023-05-26 | $24.10 | $24.55 | $23.95 | $23.98 | 426 539 |
| 2023-05-25 | $24.61 | $24.68 | $23.98 | $24.52 | 542 974 |
| 2023-05-24 | $25.13 | $25.13 | $24.59 | $24.69 | 438 827 |
| 2023-05-23 | $24.75 | $25.67 | $24.63 | $25.15 | 756 072 |
| 2023-05-22 | $24.10 | $24.81 | $24.10 | $24.64 | 459 752 |
| 2023-05-19 | $24.23 | $24.29 | $23.92 | $24.10 | 444 288 |
| 2023-05-18 | $24.25 | $24.41 | $23.83 | $24.05 | 553 188 |
| 2023-05-17 | $24.35 | $24.68 | $24.17 | $24.44 | 615 199 |
| 2023-05-16 | $24.06 | $24.39 | $23.79 | $24.29 | 554 983 |
| 2023-05-15 | $23.77 | $24.28 | $23.69 | $24.06 | 582 958 |
| 2023-05-12 | $23.84 | $23.97 | $23.57 | $23.64 | 522 585 |
| 2023-05-11 | $23.97 | $24.03 | $23.73 | $23.91 | 540 218 |
| 2023-05-10 | $23.93 | $24.18 | $23.76 | $24.00 | 506 893 |
| 2023-05-09 | $23.58 | $24.04 | $23.51 | $23.82 | 603 886 |
| 2023-05-08 | $23.98 | $24.18 | $23.75 | $23.76 | 681 749 |
| 2023-05-05 | $24.19 | $24.19 | $23.55 | $24.07 | 532 376 |
| 2023-05-04 | $23.20 | $24.15 | $21.84 | $24.00 | 1 073 774 |
| 2023-05-03 | $22.65 | $23.33 | $22.05 | $23.10 | 1 285 830 |
| 2023-05-02 | $22.65 | $22.98 | $22.37 | $22.39 | 1 178 969 |
| 2023-05-01 | $22.40 | $22.89 | $22.30 | $22.77 | 1 118 587 |
| 2023-04-28 | $22.37 | $22.93 | $22.27 | $22.53 | 718 286 |
| 2023-04-27 | $22.36 | $22.45 | $22.06 | $22.31 | 543 077 |
| 2023-04-26 | $22.16 | $22.26 | $21.93 | $22.23 | 499 260 |
| 2023-04-25 | $22.42 | $22.59 | $22.10 | $22.25 | 447 271 |
| 2023-04-24 | $22.46 | $22.59 | $22.23 | $22.50 | 496 617 |
| 2023-04-21 | $22.31 | $22.51 | $21.97 | $22.46 | 611 996 |
| 2023-04-20 | $22.11 | $22.37 | $22.02 | $22.30 | 636 612 |
| 2023-04-19 | $22.07 | $22.22 | $21.87 | $22.10 | 693 601 |
| 2023-04-18 | $22.49 | $22.49 | $21.98 | $22.15 | 702 847 |
| 2023-04-17 | $22.28 | $22.74 | $22.17 | $22.46 | 481 329 |
| 2023-04-14 | $22.53 | $22.60 | $21.87 | $22.17 | 708 607 |
| 2023-04-13 | $21.87 | $22.55 | $21.77 | $22.53 | 815 268 |
| 2023-04-12 | $22.25 | $22.32 | $21.66 | $21.74 | 958 414 |
| 2023-04-11 | $22.42 | $22.66 | $21.90 | $22.06 | 1 333 106 |
| 2023-04-10 | $22.20 | $22.65 | $22.07 | $22.63 | 860 871 |
| 2023-04-06 | $21.92 | $22.30 | $21.76 | $22.29 | 633 348 |
| 2023-04-05 | $22.00 | $22.29 | $21.78 | $21.82 | 1 376 992 |
| 2023-04-04 | $23.03 | $23.04 | $21.00 | $22.02 | 2 397 611 |
| 2023-04-03 | $22.04 | $22.55 | $21.81 | $22.51 | 1 586 968 |
| 2023-03-31 | $21.93 | $21.93 | $21.58 | $21.66 | 1 167 069 |
| 2023-03-30 | $21.91 | $21.91 | $21.45 | $21.63 | 1 247 787 |
| 2023-03-29 | $21.91 | $21.96 | $21.70 | $21.77 | 1 833 687 |
| 2023-03-28 | $21.63 | $21.87 | $21.61 | $21.85 | 1 138 903 |
| 2023-03-27 | $21.88 | $21.92 | $21.61 | $21.64 | 1 077 833 |
| 2023-03-24 | $21.13 | $21.78 | $21.09 | $21.77 | 708 977 |
| 2023-03-23 | $20.99 | $21.31 | $20.95 | $21.11 | 575 371 |
| 2023-03-22 | $21.21 | $21.28 | $20.84 | $20.84 | 1 051 031 |
| 2023-03-21 | $21.04 | $21.46 | $20.84 | $21.25 | 1 349 582 |
| 2023-03-20 | $20.76 | $20.96 | $20.60 | $20.90 | 649 886 |
| 2023-03-17 | $20.86 | $20.98 | $20.54 | $20.64 | 1 622 198 |
About Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have ... CORT Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
